Shares of RTW Biotech Opportunities (LON:RTW - Get Free Report) were up 0.4% during trading on Friday . The stock traded as high as GBX 1.20 ($0.02) and last traded at GBX 1.20 ($0.02). Approximately 210,063 shares traded hands during mid-day trading, a decline of 17% from the average daily volume of 252,410 shares. The stock had previously closed at GBX 1.19 ($0.02).
RTW Biotech Opportunities Trading Down 2.5%
The stock's 50 day moving average price is GBX 1.17 and its two-hundred day moving average price is GBX 1.29. The firm has a market capitalization of £389.66 million, a PE ratio of 2.77 and a beta of 0.60.
About RTW Biotech Opportunities
(
Get Free Report)
RTW Biotech Opportunities Ltd LSE: RTW is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Featured Stories
Before you consider RTW Biotech Opportunities, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RTW Biotech Opportunities wasn't on the list.
While RTW Biotech Opportunities currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
